stockportfolio.pro
Harmony Biosciences Holdings, Inc. Revenue 2019–2025
Harmony Biosciences Holdings, Inc. (HRMY) annual revenue by fiscal year, computed from SEC filings. Compound growth +129.2%/yr over 6 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $868.45M | +21.5% |
| FY 2024 | $714.73M | +22.8% |
| FY 2023 | $582.02M | +32.9% |
| FY 2022 | $437.86M | +43.4% |
| FY 2021 | $305.44M | +91.2% |
| FY 2020 | $159.74M | +2564.6% |
| FY 2019 | $6.00M | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s revenue?
Harmony Biosciences Holdings, Inc. (HRMY) reported revenue of $868.45M for fiscal year 2025, per its SEC filings.
How has Harmony Biosciences Holdings, Inc.'s revenue changed over time?
Between fiscal 2019 and 2025, HRMY's revenue grew at roughly 129.2% per year (compound annual rate), from $6.00M to $868.45M.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.